SRV Hospitals has raised Rs 140 crore from InvAscent, a life sciences private equity (PE) fund. This investment marks a pivotal moment for SRV, enabling the group to strengthen and amplify its multispecialty critical care-focused healthcare model.
It is a bold step forward in The New Possible—SRV’s mission to redefine how accessible tertiary care is imagined, delivered, and experienced. The funding positions SRV for its next chapter, setting new benchmarks in the healthcare sector, while deepening its commitment to advanced critical & surgical care, empowered clinicians, and elevated patient experience.
Founded in 2015, SRV Hospitals has rapidly evolved into a benchmark in high-acuity neighbourhood healthcare, operating five advanced tertiary care hospitals across Mumbai, Nashik, and Bengaluru with a combined capacity of 500+ beds.
The group has earned deep trust across patients, clinicians, and healthcare professionals alike, driven by a model built on consultant-led care, robust critical care systems & protocols, superior clinical outcomes, and a relentless focus on patient experience.
InvAscent’s decision to back SRV follows the PE fund’s successful investments in top-tier healthcare brands like HCG Hospitals and Dr. Agarwal’s Eye Hospital. The firm brings not only capital, but deep sector insights and long-term strategic vision. With this partnership, SRV will accelerate its presence, invest in cutting-edge technology, and further strengthen the systems that make its current institutions stand out.
